Latest Schedule 13D activist filings
Steel Partners Holdings L.P. and its affiliates have reduced their beneficial ownership in Green Dot Corp Class A Common Stock to 5.7% through recent open market sales.
NASDAQ
FLNT
Fluent, INCPhillip Frost, M.D. and Frost Gamma Investments Trust have updated their beneficial ownership in Fluent, Inc. to 24.7% of common stock.
AMEX
FLYX
Flyexclusive INCGregg S. Hymowitz and affiliated entities significantly increased their beneficial ownership in flyExclusive, Inc. following the conversion of preferred stock to common shares.
NASDAQ
BELFA
Bel Fuse INC /NJA group of entities associated with Mario Gabelli has reported a decrease in their collective beneficial ownership of Bel Fuse Inc. Class A Common Stock to 5.84%.
NYSE
Saba Capital Management, L.P. and its affiliates have reduced their beneficial ownership in AllianceBernstein National Municipal Income Fund, Inc. to 7.92%.
Magnetar Financial and its affiliates report the cancellation of all 3.43 million Astria Therapeutics shares following the company's merger at $8.55 per share.
NYSE
SCHEDULE 13D/A: Mnuchin Joins Lionsgate Studios Board, Standstill Pact Signed
Steven T. Mnuchin has been appointed to the Lionsgate Studios Corp. Board of Directors following a new governance and standstill agreement with Liberty Parties and MHR Fund Management.
AMEX
SCHEDULE 13D/A: Paulson & Co. Boosts Stake in International Tower Hill Mines
Paulson & Co. Inc. increased its beneficial ownership in International Tower Hill Mines Ltd. to 34% through a $40 million private placement.
NASDAQ
ZURA
Zura Bio LTDAthanor Capital and UGS Capital LLC report a 15.7% beneficial ownership in Zura Bio Limited, with a director from the group re-appointed to the board.
NASDAQ
SCHEDULE 13D/A: SKYX Platforms: Shiff Group Ownership Update
Dov Shiff and affiliated entities updated their beneficial ownership in SKYX Platforms Corp., now holding 11.7% of outstanding common stock.
NASDAQ
SCHEDULE 13D/A: Frazier Life Sciences Amends Mirum Pharma Stake
Frazier Life Sciences funds and affiliates updated their beneficial ownership in Mirum Pharmaceuticals, detailing recent share acquisitions and a merger-related stock issuance.
NASDAQ
SCHEDULE 13D/A: OrbiMed's Corvus Stake Dips Post-Offering
OrbiMed Advisors' beneficial ownership in Corvus Pharmaceuticals decreased to 10.3% following Corvus's recent public offering of 7.9 million shares.
AMEX
SCHEDULE 13D/A: Diveroli Group Exits Battalion Oil Stake
Diveroli Investment Group and Kingbird Ventures have fully divested their 5.39% stake in Battalion Oil Corp, ceasing all plans related to the issuer.
NASDAQ
APPN
Appian CORPSCHEDULE 13D: Fivespan Partners Discloses 6.2% Stake in Appian Corp
Fivespan Partners, LP and Dylan Haggart have disclosed a 6.2% beneficial ownership stake in Appian Corp, citing undervaluation and plans for strategic discussions.
NASDAQ
SCHEDULE 13D/A: Caligan Partners Amends Anika Therapeutics Stake Disclosure
Caligan Partners LP updated its Schedule 13D filing for Anika Therapeutics, Inc., detailing derivative agreements representing 4.3% economic exposure.
NASDAQ
BDSX
Biodesix INCSCHEDULE 13D/A: Biodesix Insider Jack Schuler Boosts Stake to 24%
Jack W. Schuler, an emeritus director of Biodesix Inc., increased his beneficial ownership in the company to 24.0% through recent open market purchases.
AMEX
SCHEDULE 13D: Star Equity Group Discloses 6% Stake in Air Industries
Star Equity Fund and CEO Jeffrey E. Eberwein have disclosed a combined 6.0% beneficial ownership stake in Air Industries Group, citing undervaluation and attractive investment opportunity.
SCHEDULE 13D/A: Prudential Affiliates Boost PGIM Private Credit Fund Holdings
Prudential Financial affiliates increased their beneficial ownership in PGIM Private Credit Fund through dividend reinvestment and a significant share purchase.
NASDAQ
AIMD
Ainos, INCSCHEDULE 13D: ScentAI Inc. Discloses 16.5% Stake in Parent Ainos, Inc.
ScentAI Inc., a wholly-owned subsidiary of Ainos, Inc., reported acquiring 1,160,000 shares of Ainos Common Stock, representing 16.5% of the class, for investment and general corporate purposes.
NASDAQ
SCHEDULE 13D/A: K Wave Media Insiders Adjust Significant Shareholdings
Several key insiders of K Wave Media Ltd. have significantly reduced their beneficial ownership, while one increased their stake, as detailed in a recent Schedule 13D amendment.
NYSE
SCHEDULE 13D/A: MHR Fund Management, Liberty77 Ink Lionsgate Governance Pact
MHR Fund Management and Liberty77 Capital have entered a new governance and voting agreement with Lionsgate Studios Corp., leading to a new board appointment and standstill provisions.
NYSE
Hoak Public Equities and affiliated entities have reduced their beneficial ownership in Natural Gas Services Group Inc. below the 5% threshold, triggering an exit filing.
NASDAQ
SCHEDULE 13D/A: Activist Group Eyes Mawson Control, Proposes Tender Offer
A group of investors, led by Endeavor Blockchain, LLC, has amassed a 46.8% stake in Mawson Infrastructure Group Inc. and is pushing for strategic changes, including a potential tender offer and board control.
OQB
SCHEDULE 13D/A: Nuo Therapeutics Secures $200K Loan, Insider Boosts Stake
Nuo Therapeutics, Inc. has secured a $200,000 loan from insider Scott M. Pittman, who increased his beneficial ownership to 11.6% through new warrants.
OQX
SCHEDULE 13D/A: Nobility Homes Insider Sells 100K Shares, Retains 50% Stake
Terry E. Trexler, through his revocable trust, sold 100,000 shares of Nobility Homes, Inc. common stock back to the company, maintaining a 50% beneficial ownership.
NASDAQ
SCHEDULE 13D/A: Perceptive Funds Trim Trinity Biotech Stake Amid Price Decline
Perceptive Credit Holdings II, L.P. sold nearly 2 million American Depositary Shares of Trinity Biotech plc between December 2025 and January 2026, with prices declining significantly.
NYSE
SCHEDULE 13D: Birkenstock Ownership Structure Simplified Post-IPO
Entities related to Christian Birkenstock have simplified their ownership structure in Birkenstock Holding plc, consolidating 7.6% of ordinary shares.
NASDAQ
SCWO
374water INCSCHEDULE 13D/A: Nagar Exits 374Water Group, Board Changes Ahead
Yaacov Nagar has filed an amended Schedule 13D, indicating his departure from a previously disclosed group and detailing board changes at 374Water Inc. following a reverse stock split.
SCHEDULE 13D/A: OceanPal Insider Ownership Drops to 19.47%
Semiramis Paliou and affiliated entities report a decrease in beneficial ownership of OceanPal Inc. common stock to 19.47% following preferred stock sales and a board resignation.
SCHEDULE 13D/A: OceanPal Insider Ownership Shifts to 7.52%
Ioannis Zafirakis and Abra Marinvest Inc. report a decrease in their beneficial ownership of OceanPal Inc. common stock to 7.52% following preferred stock transactions.